CD40 is known as an important T-B cell interaction molecule which rescues B lymphocytes from undergoing apoptosis. Like other receptors of the tumor necrosis factor (TNF) receptor gene family, CD40 is expressed on cells of different tissue origins including some transformed cells. In contrast to its well-studied effects on B cells, the biological functions of CD40 in nonimmune cells remain largely unknown. Here we show that CD40 ligation induces apoptotic cell death in transformed cells of mesenchymal and epithelial origin. This CD40-mediated cell death seems to use a preformed signaling pathway since it occurs even when protein synthesis is blocked. Notably, the CD40 cytoplasmic domain shares a structural homology with the recently defined "death domains" of the 55-kD TNF receptor (p55TNFR) and Fas. Despite these structural similarities, differences are seen in the way phorbol myristate acetate, interleukin 1, TNF, and various metabolic inhibitors influence the cellular responsiveness to CD40, p55TNFR, and Fas-mediated killing. Our study indicates that CD40 induces celt death by a distinct mechanism. p }rogrammed cell death (apoptosis) serves as a crucial control mechanism not only during embryogenesis for the development of organs but also in the mature organism for the maintenance of tissue homeostasis. In the immune system the development of T and B lymphocytes depends on a selection process involving the controlled triggering of cell death (reviewed in [1]). CTL also eliminate their targets via specific induction of cell death (reviewed in [2] ). The broadly expressed receptors Fas/APO-1 (3, 4) and 55-kD TNF receptor (p55TNF1K) (5-7), both members of the TNF1K gene family, function as membrane triggers for apoptosis in various target cells that are susceptible to CTL, e.g., virus-infected or cancer cells (8).
p }rogrammed cell death (apoptosis) serves as a crucial control mechanism not only during embryogenesis for the development of organs but also in the mature organism for the maintenance of tissue homeostasis. In the immune system the development of T and B lymphocytes depends on a selection process involving the controlled triggering of cell death (reviewed in [1] ). CTL also eliminate their targets via specific induction of cell death (reviewed in [2] ). The broadly expressed receptors Fas/APO-1 (3, 4) and 55-kD TNF receptor (p55TNF1K) (5-7), both members of the TNF1K gene family, function as membrane triggers for apoptosis in various target cells that are susceptible to CTL, e.g., virus-infected or cancer cells (8) .
For both p55TNF1K and Fas, a motif spanning 65 amino acids within the cytoplasmic regions is essential and sufticient for their cytotoxic function and has been named the death domain (9, 10) . A similar motif was found in the cytoplasmic domain of CD40, which belongs to the same receptor family (4, 11) . However, in B lymphocytes CD40 provides signals that rescue them from apoptotic death and therefore has been aptly described as an antiapoptotic molecule (12) (13) (14) . The ligand of CD40 (CD40L) 1 is a type II transmembrane molecule with a homology to TNF, lymphotoxin-ot and [3, and the Fas ligand (15) (16) (17) ; it is expressed on activated T lymphocytes. The interaction of CD40 and CD40L is crucial for many other B cell functions, including isotype switching (18) , short-and long1Abbreviations used in this paper: BHA, butylated hydroxyanisole; BHK, baby hamster kidney; BHKcD40L, BHK cells transfected with CD40L cDNA; BHKwt, BHK wild-type cells; CD40L, ligand of CD40; CHX, cycloheximide; NF-KB, nuclear factor KB; SN, supematants.
term proliferation (19, 20) , homotypic adhesion (21) , and the upregulation of BT/BB-1 (CDS0) (22) . Interestingly the hyper IgM syndrome, a severe immunodeficiency which is characterized by an isotype switch defect, was found to result from a mutated CD40L gene (23) (24) (25) (26) . A similar defect was seen in CD40-or CD40L-deficient mice (27, 28) .
Intracellular signals delivered via CD40 in B cells include the activation of several serine and threonine specific protein kinases (29, 30) , the phosphorylation of src type kinases and of the phospholipase C'y2 and the phosphatidylinositol-3 kinase (31) . The first clues of how CD40 is coupled to intracellular signaling pathways were obtained with the yeast two-hybrid technique. A protein, variously named CD40bp, CRAF1, or LAP1, is apparently constitutively associated with CD40 (32) (33) (34) and plays a role in CD40-mediated upregulation of CD23 in the Burkitt's lymphoma cell line 1Kamos (35) .
Like the TNF1K and Fas, CD40 is not only expressed on hematopoietic cells but also on dendritic cells (36) , thymic epithelium (37), basal epithelium as well as on carcinomas and other transformed cells (11, (38) (39) (40) . However, the functional properties and signaling mechanisms of CD40 in non-B cells are largely unknown. We have recently shown that CD40 induces nuclear factor-KB (NF-KB) and IL-6 production in a human fibroblast cell line and in CD40-transfected HeLa cells (41) . CD40 shares these functions with the p55TNF1K and Fas (42) . As the CD40 cytoplasmic domain and the death domains of the p55TNF1K and Fas are homologous we were interested to know whether CD40 might also induce signals leading to cell death.
The present study demonstrates that CD40 stimulation induces apoptosis in transformed cells of mesenchymal and epithelial origin. The strongest effect was seen with membrane-bound CD40L. IFN-~/ treatment rendered unresponsive cells with low level CD40 expression susceptible to CD40-mediated cytotoxicity. CD40 stimulation seemed to trigger a preformed death program. Despite the structural homology to Fas and the p55TNFR, we found that reagents that modulate p55TNFR or Fas-mediated ceil death affected CD40 killing in a unique way. This indicates that CD40 signals cell death through a distinct pathway.
Materials and Methods
Cell Lines. The murine L cell derivative A9 (43) was grown in ILPMI 1640; the SV40-transformed human fibroblast cell line SV80 (44) , the cervical carcinoma cell line HeLa (CCL 2; American Type Culture Collection, !Kockville, MD) and the baby hamster kidney (BHK) cells (ACC 61; German Collection of Micro-organisms and Cell Cultures, Braunschweig, Germany) were cultured in DMEM. The culture media were supplemented with 10% heat-inactivated FCS (Biochrom, Berlin, Germany), 100 U/ ml penicillin, 0.1 mg/ml streptomycin, 1 mM sodium pyruvate, and 2 mM L-alanyl-e-glutamine. All supplements and culture media were purchased from Gibco BRL (Eggenstein, Germany).
Cloning of CD40 and CD40L cDNA and Transfection. CD40 cDNA was cloned by reverse transcriptase PC1K using total 1KNA isolated from IM-9 cells as previously described (45) . For expression, the CD40 cDNA was ligated into the mammalian expression vector pEF-BOS (46) and designated BOS-CD40. SV80, HeLa, and A9 cells were cotransfected with 25 I.tg of ApaLIdigested BOS-CD40 and 2.5 lag ofHindlII-digested pTCF plasmid encoding a neomycin resistance gene. Transfection was performed with lipofectin (Gibco BRL) according to the manufacturer's instructions. Neomycin-resistant clones were selected in 0.6 mg/ml G418 for A9, 0.8 mg/ml for SV80, and l mg/ml for HeLa transfectants. The selected A9, SV80, and HeLa clones were tested for CD40 expression using an mAb against CD40 at 5 btg/ml (G28-5 {19]) or anti-CD4 mAb (MT413) as an isotypematched control. After staining with FITC-conjugated goat antimouse F(ab')2 fragment (Dianova, Hamburg, Germany) as secondary antibody, the CD40 expression was assessed by flow cytometry (FACScan | Becton Dickinson and Co., Mountain View, CA). Cloning of the CD40L cDNA and transfection into BHK cells were done as described previously (45) .
Cytokines and Reagents. CD40L was used either in its cell surface (membrane-bound CD40L mCD40L) or in a soluble form. BHK cells transfected with CD40L cDNA (BHKcD40L) or BHK wild-type cells (BHKwt) as a control were fixed with 3% paraformaldehyde in PBS for 10 min, followed by six washing steps with PBS. This procedure prevented the attachment of the BHK cells to the microtiter plates, which might interfere with the determination of the target cell viability in cytotoxicity assays.
For the production of CD40L supernatants (SN) or control SN, BHKcD40 L cells or BHKwt were grown to subconfluency. After two washes with PBS, serum-free Hybridoma SFM medium (Gibco BILL) was added; 24 h later the culture SN were harvested, centrifuged, and filtered at 0.2 lain. The SN were pooled, concentrated in a Centriprep-10 or Centricon-10 concentrator (Amicon, Witten, Germany) and stored at -80~
Recombinant human TNF was a gift from Dr. G. Adolf Antibodies. Protein G (Pharmacia, Freiburg, Germany) purified anti-CD40 mAb G28-5 (IgG 0 was used for CD40 stimulation. The anti-p55TNFiL mAb htr-9 (IgG1) (47) was a gift from Dr. M. Brockhaus (Hoffmann Lalkoche, Basel, Switzerland), humanized monoclonal mouse antibody against Fas (lgG3) was a present from Dr. John Grayebh (Centocor, Malvern, PA). Purified murine myeloma immunoglobulins (IgGt, MOPC 21) (Sigma Chemical Co.) and anti-CD4 mAb (MT413, lgG,, kindly provided by Dr. E. P. ILieber, Institute for Immunology, Munich, Germany), were used as control antibodies. Polyclonal anti-CD40L antibodies were raised against a fusion protein consisting of the extracellular domain of the murine IL-4 receptor and CD40L as described previously (45).
Cytotoxicity Assay. Target cells were seeded in gelatin-coated flat-bottom microtiter plates (Greiner, Niirtingen, Germany) either untreated or after a 2-d pretreatment with 1,000 U/mI IFN-T. Cells were seeded at densities of I • 104 cells/well for assays performed in the absence of CHX and of 3 • 104 cells/well for assays done in the presence of CHX. The cells were allowed to grow for 24 h (the medium for IFN-y pretreated cells contained 1,000 U/ml IFN-y) and then challenged with serial dilutions of the stimulation reagents, either in the presence (50 lag/ml) or the absence of CHX. Cell viability was assessed 16-18 h later (48 h in assays without CHX) by the neutral red uptake method according to Finter et al. (48) as described previously (45) .
Acridine Orange Staining. Acridine orange (Sigma Chemical
Co.) was added to the cells at 10 ng/ml in medium for 5 min. The culture plates were briefly centrifuged at 150 g and the dye was carefully replaced by Hank's salt solution (Biochrom, Berlin, Germany). The cellular morphology was analyzed using a fluorescence microscope and photographs were taken at a 400-fold magnification.
Results

CD4OL-CD40 Interaction Induces Cell Death in Transformed Cells of Mesenchymal and Epithelial
Origin. In many transformed cell lines ligation of Fas or the TNFR leads to apoptotic cell death. Thus far, CD40's main role was seen as that of a molecule with antiapoptotic qualities. This is indeed surprising because its cytoplasmic domain is homologous to the central part of the death domains of Fas and the p55TNF1L (Fig. 1) . To investigate the functional relevance of this structural similarity we studied CD40 responses in the TNF-sensitive fibroblast cell line SV80, which expresses low levels of CD40. In previous studies it was shown that CD40, the p55TNFR and Fas (41, 42) signal NF-KB mobilization and IL-6 production in these cells. It was also seen that IFN-y pretreatment enhanced these CD40-mediated effects. Here we found that the IFN-ypretreated SV80 cells died rapidly in response to CD40 liration when protein synthesis was blocked with CHX ( IFN-~/ pretreatment of the SVS0 cells was necessary to induce susceptibility to CD40L. At the molecular level the sensitizing effect of I F N -~/ m a y be explained in two ways: IFN-'y upregulates cell surface CD40 expression (see Fig. 2 A) but it may also induce intracellular changes that increase the sensitivity to CD40-mediated killing. To distinguish between these possibilities we overexpressed CD40 in SV80 cells (SV80cD40) by transfection. In addition, we transfected the CD40 c D N A into the CD40-negative human cervical carcinoma cell line HeLa (HeLacD40) and the murine L cell derivative A9 (A9cD40) (Fig. 3 A) . Both cell lines have been characterized extensively with respect to their T N F responses. T w o CD40-expressing clones of each cell line were compared. Membrane CD40L efficiently killed the CD40 transfectants in a dose-dependent manner (Fig. 3 B) demonstrating that CD40-mediated signals are sufficient to induce cell death. In the presence of C H X , SVSOcD4o and A9cD4o responded to a similar extent (40-50% killing) (Fig. 3 /3 ) as IFN-~/-pretreated SV80 wildtype cells (Fig. 2 B) . In HeLacD40 killing was almost c o mplete ( Fig. 3/3) .
Several control experiments demonstrated that the cytotoxic effect of BHKcD40 L cells was indeed CD40 mediated: (a) stimulation with m C D 4 0 L had no significant effect on the viability of CD40-negative wild-type cells (not shown) or mock transfectants (Fig. 3 B) . (b) The cytotoxic effect o f BHKcD40 L could be blocked by pretreatment with anti-CD40L antibodies (data not shown). (c) SN from BHKcD40 L cells containing a soluble form of CD40L were also cytotoxic whereas control SN from B H I~, cells had no effect (data not shown). (d) In addition to CD40L, the anti-CD40 mAb G28-5, but not an isotype-matched control antibody, elicited a cytotoxic response in the CD40 transfectants, although the effect was weaker than that seen with m C D 4 0 L (Fig. 3 B, b, d, and f ) .
Acridine orange staining was used to assess the form of cell death induced via CD40. Microscopic examination of the stained cells of all three cell types revealed a typical apoptotic morphology after CD40 ligation showing cellular shrinkage, chromatin condensation, and clear nuclear fragmentation ( Fig. 3 B 
Influence of Protein Synthesis on CD40 Killing. SV80 and
HeLa cells are killed by CD40, p 5 5 T N F R , and Fas only when protein synthesis is blocked. In the case of T N F Rmediated cytotoxicity this was explained by the constitutive expression of resistance proteins (49) . In contrast, mouse A9 cells are sensitive to T N F and Fas cytotoxicity even in the absence of protein or R N A synthesis inhibitors. Therefore, we tested the response to CD40 ligation in A9CD40 cells with intact protein synthesis. Membrane CD40L (Fig. 4, left) , a soluble form of CD40L (not shown) and anti-CD40 antibodies had strong cytotoxic effects. CD40-killed cells again displayed a typical apoptotic morphology (Fig. 4, inset) . Unexpectedly, CD40-mediated killing was even more effective in A9 cells in the absence of C H X : a dose of mCD40L which induced complete killing o f the A9cD40 cells in the absence of C H X left 50% o f the target cells viable when protein synthesis was blocked (Fig. 4, left) . This was in clear contrast to p55TNF1L and Fas, which killed A9 cells with intact protein synthesis 100-fold (p55TNFR) and 10-fold (Fas) less eff• (Fig. 4, middle and right). Thus it appeared that the mechanisms by which CD40 induced cell death were different from both p55TNFR.-and Fas-mediated killing. 
CD40-, p55TNFR-, and Fas-inducecl Cell Death Are Regulated Differently. Sensitivity to p 5 5 T N F R cytotoxicity
can change dramatically with changes in the expression of inducible protective proteins like manganous superoxide dismutase (52), the plasminogen activator inhibitor-2 (53), and the zinc finger protein A20 (54) . In some cell types, when protein synthesis is intact, phorbol esters (i.e., PMA), IL-1 and, paradoxically, T N F , upregulate protective proteins. These render the cells resistant to a subsequent T N F challenge in the presence of C H X , as demonstrated for SV80 and HeLa cells (49) . Therefore, we tested whether PMA, IL-1, and T N F pretreatment also conferred resistance to CD40-mediated killing in these cells. In the SV80ct340 transfectants, p 5 5 T N F R -m e d i a t e d killing was markedly reduced after PMA, IL-1, or T N F prestimulation (Fig. 5, middle) ; whereas CD40-mediated cytotoxicity was not influenced by P M A or IL-1. T N F pretreatment even enhanced CD40 killing (Fig. 5, top) . A dose of m C D 4 0 L which induced 40% killing of naive SV80co40 cells killed 75% o f the TNF-pretreated targets. Pretreatment with a ligand mimetic mAb against the p 5 5 T N F R also sensitized cells for CD40 killing, indicating that this effect was mediated via the p 5 5 T N F R (data not shown). Similar results were obtained with HeLacD40 (data not shown). The influence o f PMA, IL-1, and T N F distinguished CD40 cytotoxicity not only from p55TNFR, but also from Fas-mediated cytotoxicity as this was unaffected by all three reagents (Fig. 5, bottom) .
Synergism between CD40 and p55TNFR Cytotoxicity.
The observation that target cell prestimulation with T N F resulted in enhanced CD40 cytotoxicity raised the question whether p 5 5 T N F R and CD40 synergized when stimulated simultaneously. As shown in Fig. 6 (left) , the anti-CD40 mAb G28-5 (1 ixg/ml) alone left 90% of the SV80cD40 cells viable. In combination with a marginally active T N F dose (0.08 U/ml), G28-5 killed almost 50% of the targets. W h e n applied together with a half-maximal killing dose of T N F (0.4 U/ml), G28-5 induced > 9 0 % killing. Inversely, in the presence of 1 Ixg/ml G28-5 the T N F dose required for 50% killing was 15-fold reduced and the dose yielding 90% cell death was 60-fold reduced (Fig. 6, right) . A control experiment with the ligand mimetic anti-p55TNFP, mAb, htr-9, revealed that the T N F effect was mediated via the p55TNFP,. (not shown). Synergism between CD40 and p55TNFP, killing was seen also with HeLacD40 and A9CD40 (not shown) suggesting that it was not restricted to one particular cell type. The question whether CD40 synergized with Fas killing could not be definitely answered. Augmentation o f Fas cytotoxicity was only seen in I F N -y -p r e t r e a t e d SV80cD40 cells. Here, the dose of anti-Fas antibodies inducing halfmaximal or 90% killing could be 7.5-fold reduced when CD40 was simultaneously stimulated with 1 t~g/ml G28-5 antibody (not shown). However, this effect was additive rather than synergistic.
CD40 and the p55TNFR, not only quantitatively enhanced each other's cytotoxicity but also accelerated each other's killing. Cell death in G28-5 (1 I~g/ml)-stimulated A9 fibroblasts was detectable after 6-9 h, increased within the next 16 h in a linear fashion, and reached plateau levels at 60% killing (Table 1) . At a T N F dose that was only marginally cytotoxic even after 48 h, addition of the anti-CD40 antibody led to clearly visible cell death as early as 4 h after stimulation (Table 1) . At 8 h 42% of the cells were killed and cell death gradually increased to 88% within 48 h (Table 1 ). In the HeLa transfectants significant p 5 5 T N F Ror CD40-mediated killing in the presence of C H X was observed only after 10-12 h; however, the combined activation of both receptors induced cell death after 6-8 h (not shown).
Metabolic Inhibitors Affect CD40-mediated Killing Differently than p55TNFR-and Fas-mediated Cell
Death. p 5 5 T N F t kmediated killing can be blocked by various inhibitors of signal transduction (55) . Previously such inhibitors have been used to compare p55TNFtL and Fas cytotoxicity (56) . To determine whether or not CD40 cytotoxicity was affected in the same manner as the p55TNFtL or Fas cytotoxicity, killing via all three receptors was investigated in the presence and absence of several metabolic inhibitors ( Table 2 ). All experiments were performed in A9 fibroblasts with intact protein synthesis. U n d e r these conditions some reagents that inhibit T N F cytotoxicity when R N A synthesis is blocked, i.e., the phosphatidylcholine-specific phospholipase C inhibitor D609 (56), had no effect at n o ntoxic concentrations. The oxygen radical scavenger BHA significantly reduced CD40 cytotoxicity suggesting that in A9 cells reactive oxygen intermediates might be involved not only in the p55TNFtL-but also in the CD40-activated cell death pathway. A similar result was obtained with the phosphatase inhibitor vanadate which inhibited both CD40 and p55TNFIL killing. Under these conditions Fas cytotoxicity was not affected by BHA or vanadate indicating that CD40 cytotoxicity differed from Fas killing. Use of calcium modulators also suggested that CD40 signals were different from p 5 5 T N F R -m e d i a t e d cell death signals. Both the calcium ionophore A23187 and the calmodulin inhibitor trifluoperazine decreased p55TNFiL cytotoxicity while CD40 and Fas killing were not inhibited at any concentration tested. In fact, trifluoperazine enhanced CD40 and Fas cytotoxicity.
Discussion
The discovery of CD40 had an important impact on the understanding of B cell immunity (reviewed in [57] ). A preeminent function of CD40 is its ability to rescue germinal center B cells from undergoing apoptosis (12) (13) (14) . Paradoxically, the intracellular domain of CD40 shares a structural homology with the death domains of the p55TNFtL and Fas (9, 10) . This prompted us to investigate whether or not CD40 could also mediate cytotoxicity. In three different cell lines which were chosen from two different tissue origins (mesenchymal and epithelial) and two different species (human and murine) we observed that CD40 indeed induces cell death. Regardless of the cell type examined the dying cells showed typical morphological features of apoptosis.
In view of the structural relationship between the three cell death-inducing receptors it was of interest to study whether CD40, p55TNFR, and Fas killed by similar mechanisms. Our initial findings supported this possibility. The cellular responsiveness to CD40 cytotoxicity showed a pattern similar to p55TNFR-and Fas-mediated cytotoxicity: In SV80 and HeLa, CD40 elicited a cytotoxic response only in the presence of a protein synthesis inhibitor, while the routine A9 fibroblasts were efficiently killed with intact or blocked protein synthesis. This demonstrated that CD40 stimulation activates a preformed death program which does not require the synthesis of novel proteins. Moreover, A9CD40 cells were treated in the absence of CHX with anti-CD40 mAb G28-5 at 1 p,g/ml, 200 U/ml TNF, the combination of both, or medium as a control. Cell death was determined after the indicated time intervals. Presented are the mean values of quadruplicate determinations (+ SD) of one representative experiment.
in some cell types constitutive expression of resistance proteins seemed to interfere not only with p55TNFR-and Fas-induced cytotoxicity (49, 58) but also with the CD40-induced cell death pathway. Despite these similarities, further experiments revealed several differences in CD40-and p55TNFR-induced cell death: (a) while TNF killed the murine A9 fibroblasts markedly better in the presence of CHX, CD40 cytotoxicity was much stronger in the absence of CHX. This suggested that in A9 cells CD40 not only triggered a preformed death program but also may have induced proteins that supported the induction of cell death. (b) Treatments that induced resistance to p55TNFR cytotoxicity failed to protect against cD40 and Fas killing. For example, TNF, which paradoxically induces resistance to p55TNFR,-mediated cell death, even sensitized cells for CD40 killing. (c) Simultaneous activation of the p55TNFR and CD40 was synergistic resulting both in enhanced and accelerated killing. This synergism did not result from receptor upregulation since it was also observed in the presence of CHX. (d) CD40-, p55TNFR-, and Fas-mediated killing were influenced differently by several metabolic inhibitors. Unlike Fas killing, CD40-and p55TNFP,,-mediated cytotoxicity were both inhibited by the radical scavenger BHA and the phosphatase inhibitor vanadate in A9 cells with intact protein synthesis. However, similar to Fas but unlike p55TNFR, CD40 killing could not be blocked with modulators of calcium metabolism, such as the calcium ionophore A23187 or the calmodulin inhibitor trifluoperazine. These findings suggest that the cell death pathway of CD40 may partially overlap but is not identical with the signaling pathway of either p55TNFR or Fas.
Molecular evidence for the differences in the cell death pathways triggered by p55TNFR and Fas was recently provided in several studies describing three receptor-associated proteins that can initiate cell killing (59, 62) . Although these proteins are also homologous to the death domains of p55TNFR and Fas, they specifically interact only with individual receptors. Thus it emerges that the cell death pathways of the p55TNFR and Fas differ in proximal events, nevertheless they seem to converge in an IL-l-converting enzyme-dependent route (63, 64) . Therefore, it will be interesting to search for CD40-specific associated proteins that are involved in cell death signaling and to determine whether CD40 killing also uses an IL-l-converting enzyme-dependent pathway. Recent studies suggest that CTL killing relies mainly on the action of perforin and Fas (65) ; however, the way in which a particular target cell is eliminated depends not only on the mediators expressed by the effector cell but also on the responsiveness of the target cell. Since activated T cells express not only Fas ligand but also TNF and CD40L on their surface it is possible that all three ligands constitute a cytotoxic triad. The potency of this triad is further enhanced by IFN-% a secretory product of activated T cells. IFN-'y sensitizes not only for p55TNFR (66) and Fas (67) but also for CD40-mediated killing as shown here. Such an arsenal in CTL would clarify their broad target cell spectrum and efficient rate of target cell elimination. Furthemore, target cell escape from receptor-mediated killing would occur only when all three cytotoxic mechanisms fail. Thus, a CD40-positive tumor cell that became resistant to Fas cytotoxicity, e.g., via downregnlation of the receptor or via the upregulation of inhibitory proteins like the recently cloned Fas-associated protein FAP-1 (68), may still be susceptible to TNFR or CD40 killing. Since CD40 mediates cell death in transformed cells, it can even be speculated that tumor-infiltrating lymphocytes may use this mechanism for the elimination of some tumor cells in vivo. In view of our findings, it will be important to determine whether the cytotoxic potential of CD40 can be used in cancer therapy.
